InvestorsHub Logo
Followers 88
Posts 6656
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 40591

Thursday, 09/21/2023 3:52:26 PM

Thursday, September 21, 2023 3:52:26 PM

Post# of 42810
But when you KNOW what to expect from Regulators (not a damn thing, until they must), and you KNOW how revolutionary this drug will be (in both the covid and cancer markets), it presents unparalleled life-changing, as well as life-saving, opportunity. I think management is just quietly taking advantage of this opportunity, ahead of the recall of their loaned shares.

I wonder if Humanigen had a role in the Investigator Initiated CAR-T study of the Gracell platform. And we may also have invested Humanigen funds for the Baudax/TeraImmune acquisition. I suspect investment firms could be queued-up for a private offering. And with the Jefferies and Cantor investor presentations, maybe we will see a controlled equity offering, as well. Shares could become available if the company announces a 5:1 forward stock split, and if we also deplete our open shelf registration for $80M+.